What is Cumberland Pharmaceuticals Inc.'s (CPIX) StockRank?

MoatMap's StockRank for Cumberland Pharmaceuticals Inc. (CPIX) is 65/100, with a Buy signal. This is a composite score combining Quality (50), Value (35), and Momentum (75) factor ranks across MoatMap's 20,000+ stock universe.

Does Cumberland Pharmaceuticals Inc. have an economic moat?

Cumberland Pharmaceuticals Inc. (CPIX) has a Quality factor score of 50/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Cumberland Pharmaceuticals Inc. a buy, hold, or sell?

MoatMap's current signal for Cumberland Pharmaceuticals Inc. (CPIX) is Buy, based on a StockRank of 65/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Cumberland Pharmaceuticals Inc. in?

Cumberland Pharmaceuticals Inc. (CPIX) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

CPIX

BUY

Cumberland Pharmaceuticals Inc. · Healthcare · United States · $99M · Avg Vol: $619K/d

StockRank

Get insider-trade alerts

P/E (TTM)

—

ROE

-29.8%

D/E

0.5x

Dividend %

—

COMPANY DESCRIPTION

Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription products for hospital acute care and gastroenterology. The company's competitive moat is its established commercial infrastructure and a portfolio of proprietary, FDA-approved niche drugs. Cumberland operates as a focused specialty drug manufacturer with a targeted sales force in the United States.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR	TTM
Revenue	42.0M	39.6M	37.9M	44.5M	2.0%	41.9M
EPS	-0.38	-0.44	-0.46	-0.19	—	-0.52
Shares	14.4M	14.1M	14.0M	15.0M	+4.1%	15.0M
Debt	21.0M	18.4M	20.6M	10.2M	-21.4%	10.1M
Equity	36.3M	29.6M	22.9M	24.9M	-11.8%	—
Op CF	8.5M	6.1M	-0.6M	4.9M	-16.4%	1.4M
Inv CF	-13.7M	-0.1M	57.8K	-4.7M	—	—
Fin CF	-2.1M	-7.4M	0.2M	-6.7M	—	—

Loading 1Y...

PRICE (1Y)+16.6%

SMA 50SMA 200

$6.61

RSI (14)

54.0

52W High

$8.09

From 52W High

0.8%

SCORE BREAKDOWN

Quality

ROIC

-5.8%39.6

ROE

-29.8%26.7

GP/Assets

45.3%84.7

Op. Margin

-34.3%23.9

FCF/Assets

6.4%75.7

Piotroski

668.2

Int. Cover

-4.7x28.8

D/E Ratio

0.47x31.2

Current Ratio

0.95x9.9

Value

P/E (TTM)

—N/A

EV/EBITDA

-38.3x25.0

P/FCF

20.2x54.6

P/B

5.1x27.1

P/S

2.6x60.0

Div Yield

—N/A

Momentum

52W High %

82%73.5

RS 6M

56%95.0

SMA 50/200

1.48x98.0

EPS Rev 4W

0.0%62.5

EPS Rev 12W

—N/A

EPS Improve

+127%79.2

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$99M

P/E (Forward)

52.1x

Gross Margin

82.9%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of CPIX are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
CPIX	Cumberland Pharmaceuticals Inc.(you)	$99M	65	BUY
ANIK	Anika Therapeutics, Inc.	$199M	75	BUY
SIGA	SIGA Technologies, Inc.	$223M	76	BUY
CL.CN	Cresco Labs Inc.	$263M	57	HOLD
GRIN.CN	Grown Rogue International Inc.	$109M	39	HOLD
JUSH.CN	Jushi Holdings Inc.	$83M	31	SELL
EBS	Emergent BioSolutions Inc.	$375M	81	STRONG BUY
SCYX	SCYNEXIS, Inc.	$58M	33	SELL
TKNO	Alpha Teknova, Inc.	$266M	37	HOLD
ORGO	Organogenesis Holdings Inc.	$308M	38	HOLD

Peer medians: ROE -25.5% · P/E 27.7x · Gross margin 50.5%

Cumberland Pharmaceuticals Inc. (CPIX) — Stock Score Summary

Cumberland Pharmaceuticals Inc. (CPIX) has a MoatMap StockRank of 65/100 based on Quality (50/100), Value (35/100), and Momentum (75/100) factor scores. The current signal is BUY.

Key Financial Metrics

Price	$6.61
Market Cap	$99M
P/E (Forward)	52.14
Price/Book	5.06
Return on Equity	-29.8%
Return on Invested Capital	-5.8%
Debt/Equity	0.47x
Gross Margin	82.9%
Operating Margin	-34.3%
Revenue Growth	-22.0%
Free Cash Flow	$5M

Cumberland Pharmaceuticals Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Cumberland Pharmaceuticals Inc.’s (CPIX) StockRank?: MoatMap’s StockRank for Cumberland Pharmaceuticals Inc. (CPIX) is 65/100, with a Buy signal. It is a composite of Quality (50), Value (35), and Momentum (75) factor ranks across MoatMap’s 20,000+ stock universe.
Does Cumberland Pharmaceuticals Inc. have an economic moat?: Cumberland Pharmaceuticals Inc. (CPIX) has a Quality factor score of 50/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Cumberland Pharmaceuticals Inc. a buy, hold, or sell?: MoatMap’s current signal for Cumberland Pharmaceuticals Inc. (CPIX) is Buy, based on a StockRank of 65/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Cumberland Pharmaceuticals Inc. in?: Cumberland Pharmaceuticals Inc. (CPIX) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).